CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 124 filers reported holding CARA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,652 | -65.4% | 12,888 | -41.7% | 0.00% | – |
| Q2 2023 | $62,554 | -28.3% | 22,104 | +24.4% | 0.00% | – |
| Q1 2023 | $87,246 | -54.3% | 17,769 | 0.0% | 0.00% | – |
| Q4 2022 | $190,839 | +11.5% | 17,769 | -2.8% | 0.00% | – |
| Q3 2022 | $171,129 | -0.2% | 18,283 | -2.6% | 0.00% | – |
| Q2 2022 | $171,407 | -26.4% | 18,774 | -2.0% | 0.00% | – |
| Q1 2022 | $232,794 | -20.8% | 19,160 | -20.5% | 0.00% | – |
| Q4 2021 | $294,000 | -19.9% | 24,106 | +1.4% | 0.00% | – |
| Q3 2021 | $367,000 | -0.8% | 23,779 | -8.4% | 0.00% | – |
| Q2 2021 | $370,000 | -29.3% | 25,955 | +7.7% | 0.00% | – |
| Q1 2021 | $523,000 | +35.1% | 24,100 | -5.7% | 0.00% | – |
| Q4 2020 | $387,000 | +22.9% | 25,567 | +3.1% | 0.00% | – |
| Q3 2020 | $315,000 | -24.3% | 24,787 | 0.0% | 0.00% | – |
| Q2 2020 | $416,000 | +22.0% | 24,787 | -4.0% | 0.00% | – |
| Q1 2020 | $341,000 | -12.1% | 25,807 | +7.2% | 0.00% | – |
| Q4 2019 | $388,000 | -12.8% | 24,080 | +0.9% | 0.00% | – |
| Q3 2019 | $445,000 | -4.1% | 23,854 | +10.6% | 0.00% | -100.0% |
| Q2 2019 | $464,000 | +95.0% | 21,571 | +77.9% | 0.00% | – |
| Q1 2019 | $238,000 | +75.0% | 12,127 | +15.7% | 0.00% | – |
| Q4 2018 | $136,000 | -73.9% | 10,485 | -51.8% | 0.00% | -100.0% |
| Q3 2018 | $522,000 | +27.3% | 21,771 | +1.7% | 0.00% | – |
| Q2 2018 | $410,000 | +55.3% | 21,405 | +0.5% | 0.00% | – |
| Q1 2018 | $264,000 | -0.8% | 21,291 | -2.0% | 0.00% | – |
| Q4 2017 | $266,000 | -8.3% | 21,715 | +2.7% | 0.00% | – |
| Q3 2017 | $290,000 | -11.6% | 21,146 | -0.6% | 0.00% | – |
| Q2 2017 | $328,000 | -0.6% | 21,280 | +18.7% | 0.00% | – |
| Q1 2017 | $330,000 | +124.5% | 17,927 | +13.1% | 0.00% | – |
| Q4 2016 | $147,000 | +2000.0% | 15,856 | +1864.8% | 0.00% | – |
| Q3 2016 | $7,000 | +75.0% | 807 | 0.0% | 0.00% | – |
| Q2 2016 | $4,000 | -95.2% | 807 | -94.2% | 0.00% | – |
| Q1 2016 | $83,000 | -60.5% | 13,885 | +11.4% | 0.00% | – |
| Q4 2015 | $210,000 | +18.0% | 12,459 | 0.0% | 0.00% | – |
| Q3 2015 | $178,000 | +25.4% | 12,459 | +7.1% | 0.00% | – |
| Q2 2015 | $142,000 | +545.5% | 11,631 | +428.9% | 0.00% | – |
| Q1 2015 | $22,000 | 0.0% | 2,199 | 0.0% | 0.00% | – |
| Q4 2014 | $22,000 | -8.3% | 2,199 | -24.9% | 0.00% | – |
| Q3 2014 | $24,000 | -11.1% | 2,928 | +85.7% | 0.00% | – |
| Q2 2014 | $27,000 | – | 1,577 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |